Retraction
Efficacy and Safety of Ivermectin for Treatment and prophylaxis of COVID-19 Pandemic
Paper Information
Record ID:
30842
Journal:
Publication Date:
November 13, 2020
Retraction Date:
November 16, 2020
(5.0 years years ago)
Subjects:
Broad Categories:
Medicine
Medicine
Institutions:
Country:
🇪🇬 EgyptArticle Type:
Publisher:
Research Square
Open Access:
Yes
PubMed ID:
Not indexed in PubMed
Retraction PubMed ID:
Not indexed in PubMed
Retraction Details
Citations (19)
19
Total Citations19
Post-Retraction(100.0%)
0
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
10
Within 1 year
2
After 2+ years
1232
Days since retraction (latest)
Assessment of the efficiency of treatment of patients with COVID-19 (literature review)
В. Д. Москалюк, І. В. Баланюк, М. О. Андрущак et al. (7 authors)
Medicni perspektivi
Open Access
Published: Apr 2024
1232 days after retraction
More Widespread use of Ivermectin for the Treatment of COVID-19 Infection could have Saved Many
Alberto Boretti, Bimal Krishna Banik
Current Organocatalysis
Published: Oct 2023
1059 days after retraction
Lactoferrin for COVID-19 prevention, treatment, and recovery
Ecem Bolat, Furkan Eker, Merve Kaplan et al. (8 authors)
Frontiers in Nutrition
Open Access
Published: Nov 2022
42 citations
42 citations
721 days after retraction
Identifying and managing problematic trials: a Research Integrity Assessment (RIA) tool for randomized controlled trials in evidence synthesis
Stephanie Weibel, Maria Popp, Stefanie Reis et al. (6 authors)
medRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Jun 2022
5 citations
5 citations
566 days after retraction
Antimicrobials in COVID-19: strategies for treating a COVID-19 pandemic
Ajay Kumar Shukla, Saurav Misra
Journal of Basic and Clinical Physiology and Pharmacology
Open Access
Published: May 2022
5 citations
5 citations
533 days after retraction
Ivermectin and the Integrity of Healthcare Evidence During COVID-19
Dónal P O’Mathúna
Frontiers in Public Health
Open Access
Published: Mar 2022
10 citations
10 citations
470 days after retraction
Ivermectin: Evaluation of Efficacy and Safety in COVID-19
Е. В. Шубникова, N. A. Susekova, Т. М. Букатина et al. (5 authors)
Safety and Risk of Pharmacotherapy
Open Access
Published: Mar 2022
470 days after retraction
Association of County-Level Prescriptions for Hydroxychloroquine and Ivermectin With County-Level Political Voting Patterns in the 2020 US Presidential Election
Michael L. Barnett, Marema Gaye, Anupam B. Jena et al. (4 authors)
JAMA Internal Medicine
Open Access
Published: Feb 2022
15 citations
15 citations
459 days after retraction
Correction: Cruciani et al. Ivermectin for Prophylaxis and Treatment of COVID-19: A Systematic Review and Meta-Analysis. Diagnostics 2021, 11, 1645
Mario Cruciani, Ilaria Pati, Francesca Masiello et al. (6 authors)
Diagnostics
Open Access
Published: Dec 2021
3 citations
3 citations
393 days after retraction
Identification and Development of Therapeutics for COVID-19
Halie M. Rando, Nils Wellhausen, Soumita Ghosh et al. (23 authors)
mSystems
Open Access
Published: Nov 2021
19 citations
19 citations
351 days after retraction
The uses and abuses of systematic reviews
Edmund J. Fordham, Theresa A Lawrie, Katherine S. MacGilchrist et al. (4 authors)
Unknown Journal
Published: Oct 2021
2 citations
2 citations
325 days after retraction
The lesson of ivermectin: meta-analyses based on summary data alone are inherently unreliable
Jack M. Lawrence, Gideon Meyerowitz‐Katz, James Heathers et al. (5 authors)
Nature Medicine
Open Access
Published: Sep 2021
72 citations
72 citations
310 days after retraction
Use and abuses of systematic reviews
Edmund J. Fordham, Theresa A Lawrie, Katherine S. MacGilchrist et al. (4 authors)
Unknown Journal
Published: Sep 2021
291 days after retraction
Current status of therapeutic alternatives for COVID-19: A narrative review
Abdullah Tarık Aslan, Murat Akova
Infezioni in Medicina
Open Access
Published: Sep 2021
11 citations
11 citations
289 days after retraction
Effectiveness of Ivermectin-Based Multidrug Therapy in Severe Hypoxic Ambulatory COVID-19 Patients
Sabine Hazan, Sonya Davé, Anoja W. Gunaratne et al. (7 authors)
medRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Jul 2021
6 citations
6 citations
233 days after retraction
Evidence-based approach to early outpatient treatment of SARS-CoV-2 (COVID-19) infection
Drew Payne, Kimberly Sims, Cynthia Peacock et al. (5 authors)
Baylor University Medical Center Proceedings
Open Access
Published: Jun 2021
3 citations
3 citations
200 days after retraction
Ivermectin for prevention and treatment of COVID-19 infection: a systematic review, meta-analysis and trial sequential analysis to inform clinical guidelines
Andrew Bryant, Theresa A Lawrie, Therese Dowswell et al. (7 authors)
Unknown Journal
Open Access
Published: May 2021
34 citations
34 citations
182 days after retraction
Prophylaxis for covid-19: living systematic review and network meta-analysis
Jessica J Bartoszko, Reed Siemieniuk, Elena Kum et al. (40 authors)
medRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Feb 2021
7 citations
7 citations
102 days after retraction
Meta-análisis preliminar de ensayos clínicos aleatorizados de ivermectina para tratar la infección por SARS-CoV-2
Agustín Ciapponi
Evidencia actualizacion en la práctica ambulatoria
Open Access
Published: Feb 2021
79 days after retraction
Quick Stats
Total Citations:
19
Years Since Retraction:
5.0 years
Open Access:
Yes
Last Checked:
Jul 24, 2025